Sugi Predict

Sugi Predict / Compounds / SCHEMBL316901

SCHEMBL316901

SCHEMBL316901

CCCCCCCCCC(O)C(O)CCCCCCC(=O)O

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR4 Q5NUL3 2/20 0.78
▸ FFAR1 O14842 2/20 0.78
▸ GPR84 Q9NQS5 7/20 0.71
▸ PPARG P37231 7/20 0.71
▸ PPARD Q03181 7/20 0.71
▸ PPARA Q07869 7/20 0.71
▸ HDAC11 Q96DB2 5/20 0.71
▸ TSHR P16473 4/20 0.71
▸ PTPN1 P18031 3/20 0.71
▸ ALDH1A1 P00352 2/20 0.71
▸ TLR2 O60603 2/20 0.71
▸ TDP1 Q9NUW8 2/20 0.71
▸ FABP4 P15090 2/20 0.71
▸ KMT2A Q03164 2/20 0.71
▸ SLC22A6 Q4U2R8 1/20 0.71
▸ SLC22A8 Q8TCC7 1/20 0.71
▸ MEN1 O00255 1/20 0.71
▸ ESR1 P03372 1/20 0.71
▸ ALOX15 P16050 1/20 0.71
▸ PDE4A P27815 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6300670 1.00 FFAR4 (0.78) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL8539791 1.00 FFAR4 (0.78) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL10947946 1.00 FFAR4 (0.78) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL17911294 1.00 FFAR4 (0.78) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL3758559 1.00 FFAR4 (0.78) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL1275084 1.00 FFAR4 (0.78) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL10952918 1.00 FFAR4 (0.78) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL4402579 1.00 FFAR4 (0.78) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL1274520 1.00 FFAR4 (0.78) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL8633366 1.00 FFAR4 (0.78) FFAR4FFAR1GPR84PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200534-A1 Cosmetic and Pharmaceutical Compositions Comprising Lauroyl Proline and an Ester of Anhydrohexitol and of an Aliphatic Carboxylic Acid SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES (SEPPIC) (FR) 2008-08-21 — — US claimed
CN-115151246-B Vaccine adjuvants comprising inverse microlatices 化工产品开发公司SEPPIC 2025-05-13 — — CN disclosed
US-20230052315-A1 VACCINE ADJUVANT COMPRISING AN INVERSE MICROLATEX SOCIÉTÉ D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES - SEPPIC (FR) 2023-02-16 — — US disclosed
CN-115151246-A Vaccine adjuvants comprising inverse microlatex 化工产品开发公司SEPPIC 2022-10-04 — — CN disclosed
US-20180072937-A1 ADDITIVE COMPOSITIONS FOR DRILLING FLUIDS AND METHODS FOR THEIR USE THE LUBRIZOL CORPORATION 2018-03-15 — — US disclosed
CN-107750268-A Additive composition for drilling fluids and methods of use thereof 路博润公司 2018-03-02 — — CN disclosed
EP-3283596-A1 ADDITIVE COMPOSITIONS FOR DRILLING FLUIDS AND METHODS FOR THEIR USE The Lubrizol Corporation (US) 2018-02-21 — — EP disclosed
WO-2016168177-A1 ADDITIVE COMPOSITIONS FOR DRILLING FLUIDS AND METHODS FOR THEIR USE THE LUBRIZOL CORPORATION (US) 2016-10-20 — — WO disclosed
WO-2016019216-A1 ADDITIVE COMPOSITION FOR WELL TREATMENT FLUIDS AND METHODS FOR THEIR USE THE LUBRIZOL CORPORATION (US) 2016-02-04 — — WO disclosed
CN-101304726-B Cosmetic and pharmaceutical compositions comprising lauroyl proline and an ester of an anhydrohexitol and an aliphatic carboxylic acid SEPPIC SA 2013-07-17 — — CN disclosed
US-6008169-A Refrigerator oil composition comprising saturated hydroxy fatty acids and derivatives thereof IDEMITSU KOSAN CO., LTD. (JP) 1999-12-28 — — US disclosed
US-5885362-A APPLYING TO SURFACE A COMPOSITION COMPRISING A LIQUID MEDIUM AND AT LEAST ONE COMPLEXING AGENT, FOR EXAMPLE ETHYLENEDIAMINEDIORTHOHYDROXYPHENYLACETIC ACID MITSUBISHI CHEMICAL CORPORATION (JP) 1999-03-23 — — US disclosed
EP-0802254-A1 Refrigerator oil composition IDEMITSU KOSAN COMPANY LIMITED (JP) 1997-10-22 — — EP disclosed
EP-0789071-A1 METHOD FOR TREATING SURFACE OF SUBSTRATE AND SURFACE TREATMENT COMPOSITION THEREFOR MITSUBISHI CHEMICAL CORPORATION (JP) 1997-08-13 — — EP disclosed
US-5580702-A COMPRISING A PHOTOSENSITIVE ACID-GENERATING COMPOUND AND A COPOLYMER OF P-HYDROXYSTYRENE AND AN ESTER OF P-CARBOXYMETHOXYSTYRENE; NONTOXIC; STEEP WALLS; HIGH SPEED; SEMICONDUCTORS KABUSHIKI KAISHA TOSHIBA (JP) 1996-12-03 — — US disclosed
US-5403695-A Photolithography; high resolution; semiconductors KABUSHIKI KAISHA TOSHIBA (JP) 1995-04-04 — — US disclosed
US-5104737-A From polyurethanes having carboxylic amide diols and other carboxylic acid groups THE SHERWIN-WILLIAMS COMPANY (US) 1992-04-14 — — US disclosed
US-5039732-A Clear overcoating THE SHERWIN-WILLIAMS COMPANY (US) 1991-08-13 — — US disclosed
US-4912154-A Containing 4,4-bis(methylol) groups THE SHERWIN-WILLIAMS COMPANY (US) 1990-03-27 — — US disclosed
US-4303548-A Process for coating dispersed minute droplets with membrane MITSUBISHI PAPER MILLS, LTD. (JP) 1981-12-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230052315-A1 VACCINE ADJUVANT COMPRISING AN INVERSE MICROLATEX MLX, CD14, PHAX FFAR4 2501/4885FFAR1 2140/4885GPR84 2206/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.